Broncus Technologies

company

About

Broncus Technologies is a medical technology company developing minimally-invasive medical devices for emphysema and other lung diseases.

  • 51 - 100

Details

Last Funding Type
Series E
Last Funding Money Raised
$15.80M
Industries
Biotechnology,Health Care,Medical,Medical Device
Founded date
Jan 1, 1997
Number Of Employee
51 - 100
Operating Status
Active

Broncus Technologies is a medical technology company focused on developing minimally-invasive medical devices for emphysema and other lung diseases. Broncus is investigating the Exhale emphysema product line to perform our patented treatment method called Airway Bypass. Airway Bypass could be the first minimally-invasive procedure for the treatment of homogeneous, or diffuse, emphysema, which constitutes the majority of the emphysema patient population.

Broncus is currently enrolling patients worldwide in our pivotal EASE Trial investigating a treatment of severe homogeneous emphysema.

Broncus is located in Mountain View, CA (San Francisco Bay area).

Broncus International is located in Nyon, Switzerland.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
5
$103.30M
Broncus Technologies has raised a total of $103.30M in funding over 2 rounds. Their latest funding was raised on Jan 28, 2021 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 28, 2021 Series D 1 Detail
Dec 5, 2008 Series G $38M 2 Detail
Sep 1, 2006 Series F $29.50M 1 Detail
May 25, 2004 Series E $15.80M 1 Detail
Apr 3, 2002 Series D $20M 1 Detail

Investors

Number of Lead Investors
Number of Investors
5
Broncus Technologies is funded by 5 investors. Valliance Capital and Charter Venture Group are the most recent investors.
Investor Name Lead Investor Funding Round
Valliance Capital Series D
Charter Venture Group Series G
JAIC America Series G
Rockport Venture Partners Series F
Boston Scientific Series E